ADVENZYMESNSEAdvanced Enzyme Technologies LimitedMediumNeutral
Announced Fri, 5 Jun · 18:00 IST

Vasant L. Rathi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

ADVENZYMES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.7%1-day move
₹367.00
prior close
₹360.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.8+2.6+2.4+2.7+1.7+0.8-1.2+1.1+0.3+1.8-16.1-13.1
Up moveDown movePending
AI summary

Vasant L. Rathi, a promoter of Advanced Enzyme Technologies, has submitted a disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation pertains to the disclosure of encumbered (pledged) shares by promoters. The specific nature of the disclosure—whether it involves creation, invocation, or release of a pledge—is not detailed in the filing. No change in overall shareholding percentage is indicated.

Likely market impact

The filing is a routine regulatory compliance disclosure related to encumbered shares. Without further detail on whether shares were newly pledged, released, or invoked, the immediate impact on the stock or shareholders is neutral. Investors should watch for follow-up disclosures to understand the direction of the change.